Task: Answer the multiple choice question.
Query: Which drug exhibits a 11.021% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a.) Cc1nc2sc3c(NCc4ccco4)ncnc3c2c2c1COC(C)(C)C2
b.) CCCc1cc2c(=O)c(-c3cscn3)c(C(=O)OCC)oc2cc1O
Answer: a. Cc1nc2sc3c(NCc4ccco4)ncnc3c2c2c1COC(C)(C)C2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1nc2sc3c(NCc4ccco4)ncnc3c2c2c1COC(C)(C)C2
Cc1nc2sc3c(NCc4ccco4)ncnc3c2c2c1COC(C)(C)C2
N-(furan-2-ylmethyl)-4,4,8-trimethyl-5-oxa-11-thia-9,14,16-triazatetracyclo[8.7.0.02,7.012,17]heptadeca-1,7,9,12(17),13,15-hexaen-13-amine